New sedative aims to make endoscopy safer and smoother

NCT ID NCT06732427

Recruiting now Symptom relief Sponsor: Affiliated Hospital of Nantong University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a new sedative, fospropofol disodium, to the standard drug propofol for people undergoing painless endoscopy. Researchers want to see if the new drug provides steady sedation with fewer side effects like low oxygen or heart problems. About 426 adults aged 50-65 will take part across multiple hospitals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: fospropofol disodium
What this could lead to: If it works, this could offer a safer sedation option for painless endoscopy with fewer breathing problems and faster recovery.
What could go wrong: This is an early-phase trial with only 426 participants, so results may not apply to everyone. The drug may not prove safer or more effective than propofol.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EFFICACY AND SAFETY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EFFICACY AND SAFETY

Contacts and locations

Locations

Affiliated Hospital of Nantong University
RECRUITING

Nantong, Jiangsu, 226001, China
Hai 'an People's Hospital
RECRUITING

Hai’an, Jiangsu, 226600, China
Qidong People's Hospital
NOT_YET_RECRUITING

Qidong, Jiangsu, 226200, China
Rudong County Hospital of Traditional Chinese Medicine
RECRUITING

Rudong, Jiangsu, 226400, China
Rugao People's Hospital
RECRUITING

Rugao, Jiangsu, 226500, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.